Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes

Sadeleştirilmiş öğe sayfası
dc.contributor.authorEsin, Ece
dc.contributor.authorOksuzoglu, B.
dc.contributor.authorBilici, A.
dc.contributor.authorCicin, I.
dc.contributor.authorKostek, O.
dc.contributor.authorKaplan, M. A.
dc.contributor.authorAksoy, S.
dc.contributor.authorAktas, B. Y.
dc.contributor.authorOzdemir, O.
dc.contributor.authorAlacacioglu, A.
dc.contributor.authorCabuk, D.
dc.contributor.authorSumbul, A. T.
dc.contributor.authorSakin, A.
dc.contributor.authorPaydas, S.
dc.contributor.authorYetisir, E.
dc.contributor.authorEr, O.
dc.contributor.authorKorkmaz, T.
dc.contributor.authorYildirim, N.
dc.contributor.authorSakalar, T.
dc.contributor.authorDemir, H.
dc.contributor.authorArtac, M.
dc.contributor.authorKaraagac, M.
dc.contributor.authorHarputluoglu, H.
dc.contributor.authorBilen, E.
dc.contributor.authorErdur, E.
dc.contributor.authorDegirmencioglu, S.
dc.contributor.authorAliyev, A.
dc.contributor.authorCil, T.
dc.contributor.authorOlgun, P.
dc.contributor.authorBasaran, G.
dc.contributor.authorGumusay, O.
dc.contributor.authorDemir, A.
dc.contributor.authorTanrikulu, E.
dc.contributor.authorYumuk, P. F.
dc.contributor.authorImamoglu, Inanc
dc.contributor.authorOyan, B.
dc.contributor.authorCetin, B.
dc.contributor.authorHaksoyler, V.
dc.contributor.authorKaradurmus, N.
dc.contributor.authorErturk, I.
dc.contributor.authorEvrensel, T.
dc.contributor.authorYilmaz, H.
dc.contributor.authorBeypinar, I.
dc.contributor.authorKocer, M.
dc.contributor.authorPilanci, K. N.
dc.contributor.authorSeker, M.
dc.contributor.authorUrun, Y.
dc.contributor.authorYildirim, N.
dc.contributor.authorEren, T.
dc.contributor.authorDemirci, U.
dc.contributor.authorTurkish Oncology Grp
dc.date.accessioned2025-10-16T15:24:38Z
dc.date.issued2019
dc.identifier.doi10.1007/s00280-018-3712-7
dc.identifier.otherWOS:000458407200014
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/8137
dc.publisherSPRINGER
dc.sourceCANCER CHEMOTHERAPY AND PHARMACOLOGY
dc.subjectPertuzumab
dc.subjectTrastuzumab
dc.subjectAntiHER2
dc.subjectVisceral metastasis
dc.subjectBrain metastasis
dc.titlePertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS